Texas Oncology Methodist Dallas Cancer Center — Dallas, Texas

Texas Oncology Methodist Dallas Cancer Center is a clinical research site located in Dallas, Texas, United States 75203.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology Methodist Dallas Cancer Center has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Castration-Resistant.

Sponsors: Agendia, Merck Sharp & Dohme LLC, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology Methodist Dallas Cancer Center?

Texas Oncology Methodist Dallas Cancer Center has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology Methodist Dallas Cancer Center conducted?

Texas Oncology Methodist Dallas Cancer Center has 7 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Castration-Resistant.

Is Texas Oncology Methodist Dallas Cancer Center accredited by Crixeo Clinical Trials?

Texas Oncology Methodist Dallas Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology Methodist Dallas Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.